{"nct_id":"NCT03116347","title":"Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects","status":"COMPLETED","status_verified_date":"2022-04","start_date":"2017-05-30","start_date_type":"ACTUAL","primary_completion_date":"2021-01-15","primary_completion_date_type":"ACTUAL","completion_date":"2021-01-15","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["TAK"]}